← Back to Clinical Trials
Recruiting NCT07314151

NCT07314151 Study on the Use of Traditional Chinese Medicine Diagnostic Tools to Assist in Identifying the Clinical Characteristics of Inflammatory Bowel Disease and Research on Metabolic Plastids of Tongue Coating

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07314151
Status Recruiting
Phase
Sponsor China Medical University Hospital
Condition Inflammatory Bowel Disease (Crohn's Disease and Ulcerative Colitis)
Study Type OBSERVATIONAL
Enrollment 200 participants
Start Date 2024-02-15
Primary Completion 2026-01-19

Trial Parameters

Condition Inflammatory Bowel Disease (Crohn's Disease and Ulcerative Colitis)
Sponsor China Medical University Hospital
Study Type OBSERVATIONAL
Phase N/A
Enrollment 200
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2024-02-15
Completion 2026-01-19
Interventions
No intervention (observational study with diagnostic assessments only)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

This study will be conducted at the outpatient clinic of China Medical University hospital. It is expected to enroll two groups of 30 subjects, including the experimental group must meet the clinical diagnosis of IBD, and the control group without IBD and have no obvious gastrointestinal symptoms . This proje ct uses modern TCM diagnostic tools, such as tongue diagnosis instrument, auscul tation instrument, TCM constitution questionnaire, and pulse diagnosis instrument to establish the comparison of physiological and biochemical indicators such as TCM phenotype and laboratory tests data in patients with IBD. Besides, another purpose of this project is to analyze the tongue coating metabolites of patients with IBD by mass spectrometry, and to establish a research model of tongue coating an d metabolomics for patien ts with IBD and the prognosis analysis of acute and remission phases.

Eligibility Criteria

Inclusion Criteria: * Adult patients aged 18 years or older who are able to provide informed consent and comply with the study procedures. * Experimental group: Patients with a primary diagnosis of Crohn's disease or ulcerative colitis, defined by ICD-10-CM codes K50-K51. * Control group: Individuals without inflammatory bowel disease and without significant gastrointestinal symptoms. Exclusion Criteria: * Individuals who are unable to provide informed consent or unable to comply with study procedures or questionnaires. * Individuals who have undergone major surgery or received chemotherapy or radiotherapy within the past month. * Pregnant women. * Individuals deemed unsuitable for participation in this study by the attending physician. * Control group exclusions: * Individuals with any diagnosed psychiatric disorder. * Individuals with any major gastrointestinal disease, such as gastrointestinal malignancy.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology